文献速递颈动脉与弓上血管

血流动力学不稳定可预测经颈动脉血运重建和经股动脉颈动脉支架置入术后院内及1年死亡率

Hemodynamic instability predicts in-hospital and 1-year mortality after transcarotid artery revascularization and transfemoral carotid stenting.
PubMed 文献 · J Vasc Surg · 2023-04-03

基于VQI数据库2016至2021年38,510例颈动脉支架置入患者,30%术后因高血压或低血压接受静脉降压药治疗。术后低血压和高血压均与院内卒中、死亡、心肌梗死及出血风险升高相关,术后高血压与1年生存率更差相关。

要点

  • 术后低血压与院内卒中、死亡、心梗及出血风险升高独立相关。
  • 术后高血压与院内卒中、死亡、心梗及出血风险升高独立相关。
  • 术后高血压与1年生存率更差相关,需密切随访和持续药物管理。

核心结论

  • 颈动脉支架置入术后因高血压或低血压需静脉降压药治疗与院内卒中、死亡、心肌梗死和出血风险增加相关。
  • 术后高血压与1年生存率更差相关。
  • 研究表明颈动脉支架置入术后需静脉降压药治疗并非良性事件,这些患者需要积极的围手术期医疗管理和安全技术以避免低血压和高血压。
  • 需要密切随访和持续医疗管理以最大化这些患者的生存率。

研究设计与样本

  • 回顾性队列研究,纳入血管质量倡议(VQI)数据库2016至2021年所有接受颈动脉血运重建的患者。
  • 共纳入38,510例颈动脉支架置入患者,其中经颈动脉血运重建占57.7%,经股动脉颈动脉支架置入占42.3%。
  • 比较术后需静脉降压药治疗高血压或低血压的患者与血压正常患者的结果。
  • 院内结果采用多变量逻辑回归比较,1年结果采用Kaplan-Meier生存分析和多变量Cox比例风险回归分析评估。

主要发现

  • 30%的患者接受了静脉降压药治疗,其中术后高血压占12.6%,低血压占16.4%。
  • 与血压正常患者相比,术后低血压与卒中、死亡或心肌梗死风险升高相关(OR 3.1,95%CI 2.6-3.6,P < .001),卒中或死亡(OR 2.9,95%CI 2.4-3.5,P < .001),卒中(OR 2.6,95%CI 2.1-3.2,P < .001),死亡(OR 3.5,95%CI 2.6-4.8,P < .001),心肌梗死(OR 4.7,95%CI 3.3-6.7,P < .001),出血(OR 1.96,95%CI 1.4-2.7,P < .001)。
  • 与血压正常患者相比,术后高血压与卒中、死亡或心肌梗死风险升高相关(OR 3.6,95%CI 3-4.4,P < .001),卒中或死亡(OR 3.3,95%CI 2.7-4.1,P < .001),卒中(OR 3.7,95%CI 3-4.7,P < .001),死亡(OR 2.7,95%CI 1.9-3.9,P < .001),心肌梗死(OR 5.7,95%CI 3.9-8.3,P < .001),出血(OR 1.9,95%CI 1.4-2.7,P < .001)。
  • 术后高血压与1年生存率更差相关。

临床怎么用

  • 作者认为颈动脉支架置入术后需静脉降压药治疗并非良性事件,这些患者需要积极的围手术期医疗管理和安全技术以避免低血压和高血压。
  • 作者指出需要密切随访和持续医疗管理以最大化这些患者的生存率。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Blood pressure fluctuations are a common hemodynamic alteration following carotid artery stenting either with transfemoral (TFCAS) or transcarotid (TCAR) approach and are thought to be related to alteration in baroreceptor function due to angioplasty and stent expansion. These fluctuations are particularly worrisome in the high-risk patient population referred for CAS. This study aims to evaluate the outcomes of patients who required the administration of intravenous blood pressure medication (IVBPmed) for hypotension or hypertension after CAS. METHODS: All patients undergoing carotid revascularization in the Vascular Quality Initiative (VQI) database between 2016 and 2021 were included. We compared outcomes of patients who required postoperative IVBPmed to treat hyper- or hypotension with normotensive patients. In-hospital outcomes were compared using multivariable logistic regression. One-year outcomes were assessed using Kaplan-Meier survival and multivariable Cox proportional hazard regression analyses. RESULTS: We identified 38,510 patients undergoing CAS (57.7% TCAR and 42.3% TFCAS), of which, 30% received IVBPmed for treatment of either postoperative hypertension (12.6%) or hypotension (16.4%). In multivariable analysis, postoperative hypotension was associated with a higher risk of stroke, death, or myocardial infarction (MI) (odds ratio [OR], 3.1; 95% confidence interval [CI], 2.6-3.6; P < .001), stroke or death (OR, 2.9; 95% CI, 2.4-3.5; P < .001), stroke (OR, 2.6; 95% CI, 2.1-3.2; P < .001), death (OR, 3.5; 95% CI, 2.6-4.8; P < .001), MI (OR, 4.7; 95% CI, 3.3-6.7; P < .001), and bleeding (OR, 1.96; 95% CI, 1.4-2.7; P < .001) compared with normotensive patients. Postoperative hypertension was associated with a higher risk of stroke, death, or MI (OR, 3.6; 95% CI, 3-4.4; P < .001), stroke or death (OR, 3.3; 95% CI, 2.7-4.1; P < .001), stroke (OR, 3.7; 95% CI, 3-4.7; P < .001), death (OR, 2.7; 95% CI, 1.9-3.9; P < .001), MI (OR, 5.7; 95% CI, 3.9-8.3; P < .001), and bleeding (OR, 1.9; 95% CI, 1.4-2.7; P < .001) compared with normotensive patients. CONCLUSIONS: Postoperative hypertension or hypotension requiring IVBPmed after CAS is associated with an increased risk of in-hospital stroke, death, MI, and bleeding. Postoperative hypertension is associated with worse survival at 1 year. This study indicates that the need for IVBPmed after CAS is not benign; therefore, these patients necessitate aggressive perioperative medical management and safe techniques to avoid hypo and hypertension. Close follow-up and continue medical management are needed to maximize these patients' survival.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Elsayed N, Chow C, Ramachandran M, et al. Hemodynamic instability predicts in-hospital and 1-year mortality after transcarotid artery revascularization and transfemoral carotid stenting. J Vasc Surg. 2023. PMID: 37019157. doi:10.1016/j.jvs.2023.03.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。